How was LUCENTIS® (ranibizumab injection) studied?
LUCENTIS was studied in 2 clinical trials to see if it could be an effective treatment for macular edema following retinal vein occlusion. The main focus of the trials was to find out if patients' vision would improve after they received LUCENTIS once a month for 6 months.
How were the results measured?
The doctors measured patients' visual acuity, or VA, throughout the study. VA is how well each eye can see fine detail clearly. Your VA score is based on how many letters you can read on an eye chart. The more letters you can see, the better your vision.
is considered perfect vision
is considered legal blindness*
*20/200 or worse with corrective lenses.
Clinical trial results
Click on a tab to see results for Branch RVO or Central RVO patients.